John Johnson, Director: Xeris Biopharma Holdings XERS Sell · Filed 25/08/15

Trade details

Type: Insider sale
Amount: $786,900
Shares · price: 107,500 sh · $7.32 a share
Held after: 833,483 sh
Stock: Xeris Biopharma Holdings XERS
Person: John JohnsonDirector
Trade date: 25/08/13
Filed: 25/08/15
Days to filing: 2 days

Sold 11.4% of holdings

Share of holding sold: 11.4%

Xeris Biopharma Holdings trades, last 26 weeks

What else happened in Xeris Biopharma Holdings around then

Filed or reported within 30 days of the trade day · 25/07/14~25/09/12

John Johnson's recent trades

John JohnsonDirector
Sell10b5-1 planXeris Biopharma Holdings
Sell10b5-1 plan
Xeris Biopharma Holdings
XERS
$91.4K
15,000 sh
$91.4K
Filed 06/05
Traded 06/04
John JohnsonDirector
Planned sale10b5-1 planXeris Biopharma Holdings
Planned sale10b5-1 plan
Xeris Biopharma Holdings
XERS
$88.4K
15,000 sh
$88.4K
Filed 06/04
Traded 06/04
John JohnsonDirector
SellAxogen
Sell
Axogen
AXGN
$478K
11,050 sh
$478K
Filed 05/08
Traded 05/07
John JohnsonDirector
Planned saleAxogen
Planned sale
Axogen
AXGN
$478K
11,050 sh
$478K
Filed 05/07
Traded 05/07
John JohnsonDirector
Planned saleXeris Biopharma Holdings
Planned sale
Xeris Biopharma Holdings
XERS
$977K
135,402 sh
$977K
Filed 25/12/19
Traded 25/12/19